Plasma MERTK Is a Promising Biomarker for the Diagnosis and Prognosis of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure
Lu Y, Xin J, Liang X, Luo J, Li P, Zhou X, Yang H, Li J, Wang Y. Plasma MERTK Is a Promising Biomarker for the Diagnosis and Prognosis of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure. The Journal Of Infectious Diseases 2024, 230: 957-969. PMID: 38373244, DOI: 10.1093/infdis/jiae079.Peer-Reviewed Original ResearchHBV-ACLF patientsChronic hepatitis BAcute-on-chronic liver failureMer tyrosine kinaseHBV-ACLFArea under the receiver operating characteristic curveNormal controlsLiver failureLiver cirrhosisHBV-related acute-on-chronic liver failurePrognosis of HBV-ACLFHepatitis B-related acute-on-chronic liver failureRisk stratification analysesReceiver operating characteristic curveCut-off valueShort-term mortalityPrognostic rolePrognostic significancePrognostic valueHepatitis BPoor prognosisMerTK expressionImmunohistochemistry stainingDiagnostic accuracyDisease progression
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply